OPHTHALMIC COMPOSITIONS OF RIFAMYCINS AND USES THEREOF

Title:

OPHTHALMIC COMPOSITIONS OF RIFAMYCINS AND USES THEREOF

Document Type and Number:

Japanese Patent JP2021073209

Kind Code:

A

Abstract:

To provide ophthalmic pharmaceutical formulations comprising a rifamycin compound.SOLUTION: Provided are ophthalmic pharmaceutical compositions or formulations comprising one or more rifamycin compounds selected from the group consisting of rifampicin, rifabutin, rifapentine. In one aspect, the invention relates to methods of treating an ocular disease, disorder or condition comprising administering to a patient in need thereof an ophthalmic composition comprising an effective amount of a rifamycin compound selected from the group consisting of rifampicin, rifabutin, rifapentine, and rifaximin.SELECTED DRAWING: None

More Like This:

JP2022512481	Modified antibodies for conjugation with transglutaminase, as well as their conjugates, methods and uses.
JPH04368374	N-DIPHENYLMETHYLPIPERAZINE DERIVATIVE

Inventors:

SERIZAWA HIROAKI

Application Number:

JP2021001928A

Publication Date:

May 13, 2021

Filing Date:

January 08, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

AMD THERAPEUTICS LLC

International Classes:

A61K31/496; A61K9/06; A61K9/08; A61K31/438; A61K31/439; A61K45/00; A61K47/02; A61K47/10; A61K47/24; A61K47/26; A61P17/02; A61P17/18; A61P25/00; A61P27/02; A61P27/06; A61P29/00; A61P31/00; A61P39/06; A61P43/00

Domestic Patent References:

JP2004075665A

2004-03-11

Foreign References:

US20080213188A1	2008-09-04
US6218368B1	2001-04-17

Other References:

"０．１％リファンピシン液の冷所および体温下での安定性と有効性の検討", 心臓病センター榊原病院雑誌　第１１巻, JPN6020033274, 2007, pages 78 - 80, ISSN: 0005049013

Attorney, Agent or Firm:

Hiroshi Kobayashi
Norio Omori
Yasuhito Suzuki

Previous Patent: 殺真菌剤としての３−アルキル−５−フルオロ−４置換イミノ−３，４−�...

Next Patent: 大環状広域スペクトル抗生物質